Clene submits CNM-Au8 new drug application to FDA for ALS
Clene announced submission of a new drug application to the FDA for CNM-Au8, intended to treat ALS.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.